Venus Remedies Ltd.

•

venusremedies.com / www.vmrcindia.comBSE: 526953NSE: VENUSREM

Market Cap₹ 2,286 Cr.

Current Price

High / Low₹ 2,044 / 424

Stock P/E20.2

Book Value₹ 535

Price to Book1.60

Dividend Yield0.58 %

ROCE20.4 %

ROE15.5 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Latest quarter profit grew 118.4% YoY, showing strong momentum
Operating margins have improved to 18.7% from 13.3%
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.48x)
Working capital cycle has improved - days down from 156 to 118
Company generates healthy free cash flow

CONS

Valuation is stretched - P/E of 20.2 is well above its own 5-year median (11.1)
Though reporting repeated profits, the company pays out little dividend (13.5%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1904.00	37.77	456833.38	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9245.00	83.91	245425.70	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4924.70	85.89	187319.76	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1135.00	25.09	113216.68	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1389.00	33.29	112211.54	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1872.15	92.52	101154.55	0.11	3620.70	2139.42	20263.10	1191.00	18.20	31.50
7.	LUPIN	2135.00	17.66	97626.26	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2345.00	47.42	96859.07	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1155.00	29.92	96405.53	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1627.00	25.22	93613.98	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2458.80	38.60	69393.40	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	VENUSREM	1709.90	19.67	2285.62	0.58	22.97	139.27	178.86	35.60	21.88	19.12

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	99	170	131	175	106	170	172	197	132	193	180	259	179
	85	157	118	154	92	157	150	171	119	163	143	200	149
Operating Profit	13	13	13	21	14	13	23	25	13	30	37	59	30
OPM %	13.66%	7.71%	9.91%	12.15%	13.49%	7.61%	13.11%	12.83%	9.59%	15.49%	20.41%	22.95%	16.81%
	2	3	2	4	2	8	12	4	8	2	2	5	3
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	7	6	6	6	6	6	5	4	6	6	6	6	7
Profit before Tax	8	10	9	19	10	15	29	25	15	26	33	58	33
Tax %	47.14%	44.67%	10.20%	35.75%	55.85%	37.47%	17.98%	40.43%	20.48%	24.84%	24.05%	24.51%	21.69%
Net Profit	4	5	8	13	4	9	24	15	12	19	25	43	26
	3.25	4.07	6.13	9.36	3.33	6.92	18.02	11.07	8.75	14.40	18.64	32.51	19.10

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	375	355	302	320	515	577	538	575	644	769	810
	328	312	268	277	468	508	476	514	569	625	654
Operating Profit	47	44	34	43	47	69	62	61	75	144	156
OPM %	12.60%	12.27%	11.36%	13.45%	9.11%	11.93%	11.44%	10.59%	11.64%	18.72%	19.25%
	3	1	-4	-5	41	8	10	11	26	11	11
Interest	36	35	25	13	13	0	0	0	0	0	0
Depreciation	39	33	33	31	34	33	31	26	22	25	25
Profit before Tax	-25	-23	-28	-6	41	45	40	47	79	131	149
Tax %	18.38%	-13.49%	4.07%	-31.36%	-32.18%	-9.66%	28.18%	34.62%	33.53%	24.00%	23.85%
Net Profit	-20	-27	-27	-8	54	49	29	31	53	99	113
EPS	0.00	0.00	0.00	0.00	43.97	37.12	21.67	22.82	39.32	74.29	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	13.46%	—

COMPOUNDED SALES GROWTH

10 Years:: 7%
5 Years:: 8%
3 Years:: 13%

COMPOUNDED PROFIT GROWTH

10 Years:: 55%
5 Years:: 13%
3 Years:: 51%

STOCK PRICE CAGR

10 Years:: 32%
5 Years:: 29%
3 Years:: 93%
1 Year:: 265%

RETURN ON EQUITY

10 Years:: 4%
5 Years:: 10%
3 Years:: 10%
Last Year:: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	12	12	12	12	12	13	13	13	13	13
	382	356	329	320	374	436	465	495	576	676
	278	255	225	154	48	39	39	39	0	11
Trade Payables	31	27	33	34	68	50	49	52	69	111
	65	99	132	124	44	40	44	42	55	65
Total Liabilities	767	748	732	644	547	578	609	641	713	876
	389	370	347	271	244	225	200	203	214	215
Capital Work in Progress	66	65	65	25	25	25	26	21	26	51
	29	0	0	0	0	0	20	19	84	238
	140	136	141	136	120	126	114	118	100	129
	0	0	0	0	0	0	0	90	99	116
Cash & Bank	3	4	1	1	30	50	53	68	78	28
	140	174	178	210	127	152	196	123	111	99
Total Assets	767	748	732	644	547	578	609	641	713	876

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	62	52	44	63	109	41	28	35	83	151
Cash from Investing	-18	-11	-11	-5	56	-17	-51	-7	-76	-182
Cash from Financing	-44	-40	-35	-72	-162	-9	0	0	0	-1
	0	0	-2	1	26	15	-23	28	7	-32

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	-16.40	-21.54	-21.97	-6.67	43.97	36.65	21.67	22.82	39.32	74.29
Book Value (₹)	319.42	298.16	276.25	269.21	313.10	336.21	357.63	380.48	441.01	515.92
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	10.00
Cash EPS (₹)	15.45	4.98	4.73	18.49	71.75	61.02	45.14	41.94	55.49	92.77
PROFITABILITY
Operating Margin %	13.42%	12.60%	12.85%	14.57%	12.56%	13.39%	13.34%	10.59%	11.64%	18.72%
Net Margin %	-5.39%	-7.49%	-8.98%	-2.57%	10.55%	8.49%	5.39%	5.30%	8.16%	12.92%
ROE %	-4.83%	-6.98%	-7.65%	-2.44%	15.10%	11.72%	6.25%	6.18%	9.57%	15.53%
ROCE %	1.50%	1.75%	-0.48%	1.15%	10.80%	9.55%	8.03%	8.77%	13.91%	20.43%
	-2.53%	-3.51%	-3.66%	-1.20%	9.11%	8.71%	4.88%	4.88%	7.76%	12.50%
EFFICIENCY
Debtor Days	47	44	46	35	16	15	39	55	53	51
Inventory Days	135	142	167	158	91	78	81	73	62	55
Payable Days	53	51	61	70	55	57	53	52	59	85
	128	135	152	123	52	35	67	77	57	21
FINANCIAL HEALTH
Debt to Equity (x)	0.78x	0.82x	0.86x	0.65x	0.12x	0.09x	0.08x	0.08x	0.00x	0.00x
Interest Coverage (x)	0.31x	0.34x	-0.12x	0.52x	4.23x	0.00x	0.00x	0.00x	0.00x	0.00x
	1.29x	1.12x	1.00x	1.31x	2.43x	3.20x	4.38x	4.96x	3.62x	2.56x
GROWTH
Revenue Growth %	-6.77%	-5.43%	-14.99%	6.09%	60.70%	12.07%	-6.77%	6.98%	12.04%	19.28%
Operating Profit Growth %	-37.18%	-11.20%	-13.30%	20.23%	38.54%	19.54%	-7.19%	0.71%	25.72%	71.15%
Net Profit Growth %	-1781.70%	-31.32%	-1.99%	69.65%	759.69%	-9.74%	-40.87%	5.30%	72.34%	88.93%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.30%	72.34%	88.93%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	14.30x	7.62x	11.11x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.86x	0.68x	1.60x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.21%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	5.64x	3.55x	6.92x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76
	1.06	1.18	1.11	1.34	2.25	1.86	2.25	2.80	2.92
	0.00	0.00	0.00	0.00	0.11	0.75	1.03	1.20	0.89
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	57.18	57.06	57.13	56.90	55.89	55.63	54.96	54.24	54.43

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-21

Shareholders meeting

2026-08-21 - Voting Results and Scrutinizer's report. Earlier submitted file was not machine readable.

2026-08-21

Shareholders meeting

2026-08-21 - Venus Remedies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 20, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-21

Amendment to AOA/MOA

2026-08-21 - Venus Remedies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.

2026-08-20

Appointment

2026-08-20 - Venus Remedies Limited has informed the Exchange regarding Appointment of Dr. Gurminder Singh Bedi as Non- Executive Independent Director of the company w.e.f. May 26, 2026.

2026-08-20

Appointment

2026-08-20 - Venus Remedies Limited has informed the Exchange regarding Appointment of Dr. (Mrs.) Manu Chaudhary as Joint Managing Director of the company w.e.f. October 01, 2026.

2026-08-20

Appointment

2026-08-20 - Venus Remedies Limited has informed the Exchange regarding Appointment of Dr. (Mrs.) Savita Gupta as Non- Executive Independent Director of the company w.e.f. December 30, 2026.

2026-08-20

Appointment

2026-08-20 - Venus Remedies Limited has informed the Exchange regarding Appointment of Mr. Saransh Chaudhary as Executive Director of the company w.e.f. May 26, 2026.

2026-08-20

Shareholders meeting

2026-08-20 - Venus Remedies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 20, 2026

2026-08-04

Copy of Newspaper Publication

2026-08-04 - Venus Remedies Limited has informed the Exchange about Copy of Newspaper Publication for social media post for awareness on transfer of shares.

News

Recent coverage and analyst commentary for VENUSREM

Loading news…

🤖

AI Stock Analyst

Venus Remedies Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1904.00

37.77

456833.38

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9245.00

83.91

245425.70

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4924.70

85.89

187319.76

0.77

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1135.00

25.09

113216.68

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1389.00

33.29

112211.54

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1872.15

92.52

101154.55

0.11

3620.70

2139.42

20263.10

1191.00

18.20

31.50

LUPIN

2135.00

17.66

97626.26

0.84

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2345.00

47.42

96859.07

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

DRREDDY

1155.00

29.92

96405.53

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1627.00

25.22

93613.98

0.25

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2458.80

38.60

69393.40

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

VENUSREM

1709.90

19.67

2285.62

0.58

22.97

139.27

178.86

35.60

21.88

19.12

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

170

131

175

106

170

172

197

132

193

180

259

179

157

118

154

157

150

171

119

163

143

200

149

Operating Profit

OPM %

13.66%

7.71%

9.91%

12.15%

13.49%

7.61%

13.11%

12.83%

9.59%

15.49%

20.41%

22.95%

16.81%

Interest

Depreciation

Profit before Tax

Tax %

47.14%

44.67%

10.20%

35.75%

55.85%

37.47%

17.98%

40.43%

20.48%

24.84%

24.05%

24.51%

21.69%

Net Profit

3.25

4.07

6.13

9.36

3.33

6.92

18.02

11.07

8.75

14.40

18.64

32.51

19.10

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

375

355

302

320

515

577

538

575

644

769

810

328

312

268

277

468

508

476

514

569

625

654

Operating Profit

144

156

OPM %

12.60%

12.27%

11.36%

13.45%

9.11%

11.93%

11.44%

10.59%

11.64%

18.72%

19.25%

-4

-5

Interest

Depreciation

Profit before Tax

-25

-23

-28

-6

131

149

Tax %

18.38%

-13.49%

4.07%

-31.36%

-32.18%

-9.66%

28.18%

34.62%

33.53%

24.00%

23.85%

Net Profit

-20

-27

-8

113

EPS

0.00

43.97

37.12

21.67

22.82

39.32

74.29

—

Dividend Payout %

0.00%

13.46%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

382

356

329

320

374

436

465

495

576

676

278

255

225

154

Trade Payables

111

132

124

Total Liabilities

767

748

732

644

547

578

609

641

713

876

389

370

347

271

244

225

200

203

214

215

Capital Work in Progress

238

140

136

141

136

120

126

114

118

100

129

116

Cash & Bank

140

174

178

210

127

152

196

123

111

Total Assets

767

748

732

644

547

578

609

641

713

876

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

109

151

Cash from Investing

-18

-11

-5

-17

-51

-7

-76

-182

Cash from Financing

-44

-40

-35

-72

-162

-9

-1

-2

-23

-32

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

-16.40

-21.54

-21.97

-6.67

43.97

36.65

21.67

22.82

39.32

74.29

Book Value (₹)

319.42

298.16

276.25

269.21

313.10

336.21

357.63

380.48

441.01

515.92

Dividend per Share (₹)

0.00

10.00

Cash EPS (₹)

15.45

4.98

4.73

18.49

71.75

61.02

45.14

41.94

55.49

92.77

PROFITABILITY

Operating Margin %

13.42%

12.60%

12.85%

14.57%

12.56%

13.39%

13.34%

10.59%

11.64%

18.72%

Net Margin %

-5.39%

-7.49%

-8.98%

-2.57%

10.55%

8.49%

5.39%

5.30%

8.16%

12.92%

ROE %

-4.83%

-6.98%

-7.65%

-2.44%

15.10%

11.72%

6.25%

6.18%

9.57%

15.53%

ROCE %

1.50%

1.75%

-0.48%

1.15%

10.80%

9.55%

8.03%

8.77%

13.91%

20.43%

-2.53%

-3.51%

-3.66%

-1.20%

9.11%

8.71%

4.88%

7.76%

12.50%

EFFICIENCY

Debtor Days

Inventory Days

135

142

167

158

Payable Days

128

135

152

123

FINANCIAL HEALTH

Debt to Equity (x)

0.78x

0.82x

0.86x

0.65x

0.12x

0.09x

0.08x

0.00x

Interest Coverage (x)

0.31x

0.34x

-0.12x

0.52x

4.23x

0.00x

1.29x

1.12x

1.00x

1.31x

2.43x

3.20x

4.38x

4.96x

3.62x

2.56x

GROWTH

Revenue Growth %

-6.77%

-5.43%

-14.99%

6.09%

60.70%

12.07%

-6.77%

6.98%

12.04%

19.28%

Operating Profit Growth %

-37.18%

-11.20%

-13.30%

20.23%

38.54%

19.54%

-7.19%

0.71%

25.72%

71.15%

Net Profit Growth %

-1781.70%

-31.32%

-1.99%

69.65%

759.69%

-9.74%

-40.87%

5.30%

72.34%

88.93%

0.00%

5.30%

72.34%

88.93%

VALUATION

P/E (x)

0.00x

14.30x

7.62x

11.11x

P/B (x)

0.00x

0.86x

0.68x

1.60x

Dividend Yield %

0.00%

1.21%

0.00x

5.64x

3.55x

6.92x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

41.76

1.06

1.18

1.11

1.34

2.25

1.86

2.25

2.80

2.92

0.00

0.11

0.75

1.03

1.20

0.89

Government

0.00

57.18

57.06

57.13

56.90

55.89

55.63

54.96

54.24

54.43

Venus Remedies Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Venus Remedies Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI